FDA Inspection 1114963 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 3002571149

The FDA completed an inspection of American Red Cross Blood Services on Dec 9, 2019 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 9, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.